Carasent ASA – Extraordinary general meeting has approved cross-border merger to effect relisting to Nasdaq Stockholm
Reference is made to Carasent AS´s (“Carasent” or the “Company”) stock exchange and press release 30 August 2024 regarding the merger plan for a cross-border merger to the effect that shareholders will have their Carasent shares one for one exchanged with Carasent SWE shares listed only on Nasdaq Stockholm (the “Relisting”) and to the calling notice 10 September 2024 for an extraordinary general meeting to resolve on the proposed cross-border merger to be held today.
The extraordinary general meeting has been held today. The cross-border merger was approved.
Please find attached the minutes with attachments from today's extraordinary general meeting in Carasent ASA (“Carasent”).
The cross-border merger and Relisting are estimated to be completed during December 2024.
Further information on key dates etc. will follow. The cross-border merger remains subject to conditions precedent, inter alia, obtaining relevant approvals from Nasdaq Stockholm and relevant governmental authorities.
For further information, please contact:
Petri Nemi, Chairman of the Board Tel: +358 40 051 149